Sonnet BioTherapeutics Prices $5 Million Public Offering; Shares Jump

MT Newswires Live11-07

Sonnet BioTherapeutics Holdings (SONN) said Wednesday it priced an underwritten public offering of 1.11 million shares of common stock and common warrants to purchase up to 2.22 million shares.

Each share and accompanying common warrant is priced at $4.50, set at market value under Nasdaq Stock Market regulations, totaling about $5 million in gross proceeds, Sonnet BioTherapeutics said.

Each warrant grants the holder two shares at an exercise price of $4.50, with a five-year term. The offering is expected to close on or about Thursday, subject to customary closing conditions, the company said.

Sonnet BioTherapeutics shares jumped past 21% in recent trading.

Price: 5.09, Change: +0.89, Percent Change: +21.19

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481937543?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-07 03:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2481937543","market":"fut","top_or_hot":-1,"title":"Sonnet BioTherapeutics Prices $5 Million Public Offering; Shares Jump","media":"MT Newswires Live","content":"<html><body><p> Sonnet BioTherapeutics Holdings (SONN) said Wednesday it priced an underwritten public offering of 1.11 million shares of common stock and common warrants to purchase up to 2.22 million shares.</p><p>Each share and accompanying common warrant is priced at $4.50, set at market value under Nasdaq Stock Market regulations, totaling about $5 million in gross proceeds, Sonnet BioTherapeutics said.</p><p>Each warrant grants the holder two shares at an exercise price of $4.50, with a five-year term. The offering is expected to close on or about Thursday, subject to customary closing conditions, the company said.</p><p>Sonnet BioTherapeutics shares jumped past 21% in recent trading.</p><p>Price: 5.09, Change: +0.89, Percent Change: +21.19</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonnet BioTherapeutics Prices $5 Million Public Offering; Shares Jump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonnet BioTherapeutics Prices $5 Million Public Offering; Shares Jump\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-07 03:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sonnet BioTherapeutics Holdings (SONN) said Wednesday it priced an underwritten public offering of 1.11 million shares of common stock and common warrants to purchase up to 2.22 million shares.Each ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2481937543","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481937543","pubTimestamp":1730920204,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sonnet BioTherapeutics Holdings  said Wednesday it priced an underwritten public offering of 1.11 million shares of common stock and common warrants to purchase up to 2.22 million shares.Each share and accompanying common warrant is priced at $4.50, set at market value under Nasdaq Stock Market regulations, totaling about $5 million in gross proceeds, Sonnet BioTherapeutics said.Each warrant grants the holder two shares at an exercise price of $4.50, with a five-year term. The offering is expected to close on or about Thursday, subject to customary closing conditions, the company said.Sonnet BioTherapeutics shares jumped past 21% in recent trading.Price: 5.09, Change: +0.89, Percent Change: +21.19","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","SONN":"Sonnet BioTherapeutics Holdings, Inc."},"translate_title":"Sonnet BioTherapeutics公开发行定价500万美元；股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SONN":0.9},"content_text":"Sonnet BioTherapeutics Holdings (SONN) said Wednesday it priced an underwritten public offering of 1.11 million shares of common stock and common warrants to purchase up to 2.22 million shares.Each share and accompanying common warrant is priced at $4.50, set at market value under Nasdaq Stock Market regulations, totaling about $5 million in gross proceeds, Sonnet BioTherapeutics said.Each warrant grants the holder two shares at an exercise price of $4.50, with a five-year term. The offering is expected to close on or about Thursday, subject to customary closing conditions, the company said.Sonnet BioTherapeutics shares jumped past 21% in recent trading.Price: 5.09, Change: +0.89, Percent Change: +21.19","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481937543"}